Aims: Growing evidence suggests that blood viscosity plays a crucial role in both the development and acceleration of atherosclerosis. In this study, aimed to investigate the diagnostic performance of the mean platelet volume-age-total protein-hematocrit (MAPH) score, a new index for blood viscosity, in predicting the presence and severity of CAD in patients with suspected coronary artery disease (CAD).
Methods: We retrospectively evaluated 431 patients who underwent coronary angiography. SYNTAX score (SS) were divided into 3 groups; low group (<22), intermediate group (22-32) and, high group (≥32). Low (LSR) and and high (HSR) shear rates were derived using values of total protein and hematocrit. The MAPH score was calculated based on the threshold values of mean platelet volume, age, total protein, and hematocrit for predicting CAD.
Results: The median LSR (60.7 vs. 43.1, p<0.001), mean HSR (17.3±1.3 vs. 16.2±1.2, p<0.001), and mean MAPH score (2.7±0.8 vs. 1.6±0.5, p<0.001) were higher in the CAD group compared to the non-CAD group. These indices of blood viscosity were found to be higher in the intermediate-high SS group compared to the low SS group. The threshold value of MAPH score for predicting CAD was >2 (sensitivity=78.2%, specificity=70.0%). It also had a graduated threshold value (>3, sensitivity=71.1%, specificity=62.5%) in distinguishing intermediate-high SS than low SS groups. In predicting both the presence and severity of CAD, the MAPH score exhibited superior diagnostic performance relative to the levels of LSR and HSR.
Conclusion: In patients with suspected CAD, a gradual increase in the MAPH score demonstrated significant diagnostic performance in distinguishing both the presence and severity of CAD. In these patients, the MAPH score may serve as a potential screening tool and can be utilized for risk stratification.
The study was performed in accordance with the Declaration of Helsinki, and was approved by the Diskapi Yildirim Beyazit Training and Research Hospital Clinical Research Ethics Committee.
Date: 12.09.2022, Decision No: 146/03
Amaç: Artan kanıtlar, kan viskozitesinin aterosklerozun hem gelişiminde hem de hızlanmasında önemli bir rol oynadığını göstermektedir. Bu çalışmada, şüpheli KAH'li hastalarda KAH'ın varlığını ve şiddetini tahmin etmede MAPH skorunun, yeni bir kan viskozitesi indeksi olan tanısal performansını incelemeyi amaçladık.
Metot: Koroner anjiyografi geçiren 431 hasta retrospektif olarak değerlendirildi. SYNTAX skoru (SS), 3 gruba ayrıldı; düşük grup (<22), orta grup (22-32) ve yüksek grup (≥32). HSR ve LSR, total protein ve hematokrit değerleri kullanılarak türetilmiştir. MAPH skoru, KAH'ı tahmin etmek için yaş, ortalama trombosit hacmi, total protein ve hematokritin eşik değerleri temel alınarak hesaplandı.
Bulgular: KAH grubunda, KAH olmayan gruba göre medyan LSR (60.7'ye karşı 43.1, p<0.001), ortalama HSR (16.2±1.2'ye karşı 17.3±1.3, p<0.001) ve ortalama MAPH skoru (1.6±0.5'e karşı 2.7±0.8, p<0.001) daha yüksekti. Kan viskozitesi indeksleri, düşük SS grubuna kıyasla orta-yüksek SS grubunda daha yüksek bulundu. KAH'ı tahmin etmek için MAPH skorunun eşik değeri >2 idi (duyarlılık=78.2%, özgüllük=70.0%). Ayrıca, düşük SS gruplarından orta-yüksek SS gruplarını ayırt etmede dereceli eşik değeri vardı (>3, duyarlılık=71.1%, özgüllük=62.5%). Hem KAH'ın varlığını hem de şiddetini tahmin etmede, MAPH skoru LSR ve HSR seviyelerine göre üstün tanısal performans sergiledi.
Sonuç: Şüpheli KAH'li hastalarda, MAPH skorundaki kademeli artış, hem KAH'ın varlığını hem de şiddetini ayırt etmede önemli bir tanısal performans gösterdi. Bu hastalarda, MAPH skoru potansiyel bir tarama aracı olarak hizmet verebilir ve risk stratifikasyonu için kullanılabilir.
Date: 12.09.2022, Decision No: 146/03
Primary Language | English |
---|---|
Subjects | Cardiology, Cardiovascular Medicine and Haematology (Other) |
Journal Section | Research Articles [en] Araştırma Makaleleri [tr] |
Authors | |
Project Number | Date: 12.09.2022, Decision No: 146/03 |
Publication Date | February 29, 2024 |
Submission Date | January 23, 2024 |
Acceptance Date | February 17, 2024 |
Published in Issue | Year 2024 Volume: 5 Issue: 1 |
TR DİZİN ULAKBİM and International Indexes (1d)
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]
Our journal is in TR-Dizin, DRJI (Directory of Research Journals Indexing, General Impact Factor, Google Scholar, Researchgate, CrossRef (DOI), ROAD, ASOS Index, Turk Medline Index, Eurasian Scientific Journal Index (ESJI), and Turkiye Citation Index.
EBSCO, DOAJ, OAJI and ProQuest Index are in process of evaluation.
Journal articles are evaluated as "Double-Blind Peer Review".